Format

Send to

Choose Destination
Breast Cancer Res Treat. 2018 Jun;169(3):407-412. doi: 10.1007/s10549-018-4692-3. Epub 2018 Feb 8.

First international TNBC conference meeting report.

Author information

1
Department of Biology, Georgia State University, Atlanta, GA, USA.
2
Novazoi Theranostics, Rolling Hills Estates, CA, USA.
3
Department of Histopathology, Nottingham City Hospital NHS Trust, Nottingham University, Nottingham, UK.
4
Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
5
The Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
6
Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
7
Weill Cornell Medicine, New York, NY, USA.
8
Department of Medicine, Breast Medical Oncology, Yale School of Medicine, Yale University, New Haven, CT, USA.
9
Slone Epidemiology Center, Boston University, Boston, MA, USA.
10
Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
11
Department of Biochemistry, Vanderbilt University, Nashville, TN, USA.
12
Section of Hematology-Oncology, Department of Medicine, The University of Chicago, Chicago, IL, USA.
13
Morehouse School of Medicine, Atlanta, GA, USA.
14
American Cancer Society, Atlanta, GA, USA.
15
Department of Radiation Oncology, Emory University, Atlanta, GA, USA.
16
Glenn Family Breast Center, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
17
Department of Biology, Georgia State University, Atlanta, GA, USA. raneja@gsu.edu.

Abstract

Recently, Georgia State University's Centennial Hall was the premier location for the 2017 International Conference on Triple Negative Breast Cancer (TNBC): Illuminating Actionable Biology, which was held from Sept. 18 to 20, 2017, in Atlanta, USA. The conference featured a stellar line-up of domestic and international speakers and diverse participants including TNBC survivors, luminaries in breast cancer research, medical students and fellows, clinicians, translational researchers, epidemiologists, biostatisticians, bioinformaticians, and representatives from the industry. This report distills the burning questions that spiked the event and summarizes key themes, findings, unique opportunities and future directions that emerged from this confluence of thought leaders.

KEYWORDS:

Immunotherapy; Molecular subtypes; Racial disparities; Targeted drugs; Triple negative breast cancer

PMID:
29417299
PMCID:
PMC5955852
[Available on 2019-06-01]
DOI:
10.1007/s10549-018-4692-3

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center